Discussion Paper
3-*
Chapter 3
Drug Policy
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
3-*
Two Classes of Drug Laws
Regulation of “legal” drugs
pharmaceutical companies
pharmacists
physicians
all others who manufacture and dispense
Criminalization of certain drugs
use
possession
sales
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
3-*
Beginnings of Regulation
Issues leading to legislation
Fraud (patent medicines)
Morality and race (drugs of abuse)
3 pieces of legislation inform current drug laws
1906 Pure Food and Drugs Act
1914 Harrison Act
18th Amendment (Alcohol Prohibition: 1918)
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Image source: Library of Congress Prints and Photographs Division (Image Ch03_09OpiumPoster1)
Fraud in patent medicines sold directly to the public
False therapeutic claims
Habit-forming drug content
3-*
Issues Leading to Legislation
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Opium
Opium smoking brought to U.S. by Chinese workers
U.S. was involved in international drug trade
Laws passed against the importation, manufacture, and use of opium
Role of racism
3-*
Issues Leading to Legislation
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Image Source: Library of Congress Prints and Photographs Division
Cocaine
Present in products:
Patent medicines
Coca-Cola
Viewed as a cause of increasing crime
Role of racism
3-*
Issues Leading to Legislation
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Image Source: National Library of Medicine
Purpose of the legislation
Prohibited interstate commerce in misbranded and adulterated food and drugs
Misbranding referred only to labeling not advertising
Later amendments for:
Testing for safety
Testing for effectiveness
3-*
1906 Pure Food and Drug Act
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
3-*
Harrison Act of 1914
Purpose of the legislation
Required those who “produce, import, manufacture, compound, deal in, dispense, or give away” certain drugs to register and pay a special tax
Initially controlled opium and cocaine
Later expanded to include other federal controlled-substance regulations
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
The Pure Food and Drugs Act (1906)
U.S. Department of Agriculture
Goal: drugs are pure and honestly labeled
Harrison Act (1914)
U.S. Treasury Department
Goal: taxation of drugs to restrict commerce in opioids and cocaine to authorized physicians, pharmacists, and legitimate manufacturers
3-*
Two Types of Regulation
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Purity
1906 Pure Food and Drug Act:
Product contents must be accurately listed on the label
Initially, FDA encouraged voluntary cooperation and compliance
1912 Sherley Amendment outlawed “false and fraudulent” therapeutic claims on labels
3-*
Regulation of Pharmaceuticals
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Safety
1906 Pure Food and Drug Act:
No legal requirement that medications be safe
1938 Food, Drug, and Cosmetic Act:
FDA became a gatekeeper and expanded greatly
Required pre-market testing for toxicity
Companies required to submit a New Drug Application (NDA)
Directions must be included:
Adequate instructions for consumer or
Drug can be used only with physician prescription
3-*
Regulation of Pharmaceuticals
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Effectiveness
1938 Food, Drug, and Cosmetic Act:
No legal requirement that medications be effective
1962 Kefauver-Harris Amendments:
Pre-approval required before human testing
Advertising for prescription drugs must include information about adverse reactions
Every new drug must be demonstrated to be effective for the illnesses mentioned on label
3-*
Regulation of Pharmaceuticals
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Preclinical research and development
Company submits “Notice of Claimed Investigational Exemption for a New Drug” (IND)
Clinical research and development
Phase One: How the drug is absorbed and excreted
Who is tested: low doses, 20-80 healthy volunteers
Phase Two: Initial effectiveness testing
Who is tested: a few hundred patients who could benefit
Phase Three: Broader effectiveness testing
Who is tested: typically 1,000-5,000 patients
3-*
Process for Introducing a New Drug
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Orphan Drug Act (1983)
Developing drugs for rare disorders
Tax and other financial incentives
Prescription Drug Marketing Act of 1988
Regulation of free samples to physicians
1997 FDA Modernization Act
Guidelines for:
postmarketing reporting of adverse effects
distribution of information on off-label uses
3-*
Additional FDA Legislation
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
1994 Dietary Supplement Health and Marketing Act
Labels must be accurate
Products can’t make unsubstantiated direct claims
Products can make general health claims
Products can be marketed without first proving safety
3-*
Dietary Supplements
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Image source: Image source: © The McGraw-Hill Companies, Inc./Jill Braaten, photographer
Early enforcement
1914 Harrison Act
Narcotics Division’s interpretation of Act led to criminalization of drug use
Physicians and pharmacists arrested
18th Amendment (Alcohol Prohibition: 1918)
Jones-Miller Act of 1922
Doubled the penalties for dealing in illegal drugs
Prison vs. rehabilitation
Congress deemed punishment ineffective
Established “Narcotic farms” for rehabilitation (1935)
3-*
Legislation of Controlled Substances
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Bureau of Narcotics
Formed in 1930 in the Treasury Department
Harry Anslinger (first “Drug Czar”)
Instrumental in passing the Marijuana Tax Act (1937)
1956 Narcotic Drug Control Act
Toughest penalties to date
Drug Abuse Control Act Amendments of 1965
Added new classes of drugs
3-*
Legislation of Controlled Substances
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Comprehensive Drug Abuse Prevention and Control Act of 1970
Replaced or updated all previous laws
Drugs controlled by the Act are under federal jurisdiction
In some cases, state and federal laws conflict
Increased funding for:
Prevention and treatment (Department of Heath and Human Services)
Direct control of drugs (Drug Enforcement Agency)
Taxation was no longer a strategy
Enforcement separated from scientific and medical decisions
3-*
Legislation of Controlled Substances
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
3-*
Controlled Substance Schedules
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
| Schedule | Criteria | Examples |
| I | High potential for abuse No accepted medical use Lack of accepted safety | Heroin, marijuana, MDMA (Ecstasy) |
| II | High potential for abuse Currently accepted medical use Abuse may lead to severe dependence | Morphine, cocaine, methamphetamine |
| III | Potential for abuse less than I and II Currently accepted medical use Abuse may lead to moderate physical dependence or high psychological dependence | Anabolic steroids, most barbiturates, Dronabinol (THC in pill form) |
| IV | Low potential for abuse relative to III Currently accepted medical use Abuse may lead to limited physical or psychological dependence relative to III | Xanax, barbital, chloral hydrate, fenfluramine |
| V | Low potential for abuse relative to IV Currently accepted medical use Abuse may lead to limited physical or psychological dependence relative to IV | Mixture with small amounts of codeine or opium |
*
Amendments to Comprehensive Drug Abuse Prevention and Control Act of 1970
1986
Stiffened possession and selling penalties
Crack vs powder cocaine sentencing
3-*
Legislation of Controlled Substances
1988
Control of drug precursors
Control of drug paraphernalia
Established the Office of National Drug Control Policy
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Penalties differ from state to state
Federal law overrides state law
Significant growth in number of Americans in prison
Increased awareness of high incarceration rate has recently led to a decline in prison population
But U.S. still has greatest proportion of citizens in prison compared to other countries
3-*
State and Local Regulations
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Figure from Drugs in Depth box in text
Examples of tested populations:
Military and federal employees
Transportation workers
Employees at private companies
Public schools employees
Testing method issues
Different test = different results
Different levels of sensitivity
Different detection ability
3-*
Federal Support for Drug Screening
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Budget
$1 billion in 1980
$25.6 billion in 2013
International programs
DEA has agents in over 40 countries
Uruguay recently legalized marijuana
United Nations has criticized government for treaty violations
Other federal agencies
Homeland Security
Federal Aviation Administration
National Park Service
3-*
Impact of Drug Enforcement
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Other costs
Maintaining prisons and caring for prisoners
Crimes committed to purchase drugs
Corruption in law enforcement
Conflicting international policy goals
Loss of individual freedom
Drug use has not been eliminated
3-*
Impact Of Drug Enforcement
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*
Approximately 10-15 percent of illegal drug supply is seized each year
When supplies are restricted:
Prices go up
Higher prices and increased difficulty in obtaining drugs may deter some users
3-*
Effectiveness of Control
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction
or distribution without the prior written consent of McGraw-Hill Education.
*